Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

Globus Medical expects the Nevro acquisition to be accretive to its earnings in the second year of operation. Globus Medical expects to report full financial results for 2024 and provide its updated ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...

Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...

Dr. Daughtry says shoes with rocker bottom soles (meaning they curve upward at the toes and heels, like a rocking chair) can ...

A New Discovery About Pain Signaling May Contribute to Better Treatment of Chronic Pain Nov. 18, 2024 — When pain signals are passed along the nervous system, proteins called calcium channels ...